More recently, Derangeon and collaborators demonstrated, in a model of progressive cardiac conduction disease, that the ventricular fibrosis that develops with aging in Scn5a+/- mice is secondary to the activation of the TGF-β1 signalling pathway73. This evidence concerns the gene SCN5A and fibrosis.